NCT06943313View on ClinicalTrials.gov

Breast Cancer PET/CT Imaging With 68Ga-pAKTi

Enrolling by invitationOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 21, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Breast CancersPIK3CA Mutation-Related TumorsPI3K Pathway Activated TumorsPET / CT
Interventions
DIAGNOSTIC_TEST

68Ga-pAKTi PET/CT probe

A total of 20 patients with breast cancer will be enrolled. Screening will be conducted within 14 days prior to administration of 68Ga-pAKTi (from Day -14 to Day -1). Subjects who meet all inclusion criteria and none of the exclusion criteria will receive an intravenous injection of 68Ga-pAKTi on Day 0, followed by PET/CT imaging.

Trial Locations (1)

Unknown

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER